| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 30 | 2024 | 400 | 3.480 |
Why?
|
| Osteonectin | 8 | 2016 | 22 | 2.390 |
Why?
|
| Neovascularization, Pathologic | 12 | 2011 | 354 | 1.080 |
Why?
|
| Cell Proliferation | 13 | 2024 | 1753 | 0.750 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2024 | 1346 | 0.730 |
Why?
|
| Extracellular Matrix | 3 | 2011 | 255 | 0.640 |
Why?
|
| DNA Methylation | 11 | 2019 | 703 | 0.610 |
Why?
|
| Naphthyridines | 1 | 2019 | 27 | 0.580 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2011 | 299 | 0.570 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2024 | 94 | 0.510 |
Why?
|
| Serum Albumin, Bovine | 1 | 2016 | 47 | 0.510 |
Why?
|
| Palmitic Acid | 1 | 2016 | 29 | 0.500 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 220 | 0.460 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1670 | 0.430 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 2778 | 0.420 |
Why?
|
| Mice, Nude | 13 | 2018 | 830 | 0.400 |
Why?
|
| Schwann Cells | 4 | 2009 | 34 | 0.380 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 130 | 0.340 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 127 | 0.340 |
Why?
|
| 5-Methylcytosine | 2 | 2024 | 122 | 0.340 |
Why?
|
| Fibroblasts | 3 | 2011 | 777 | 0.330 |
Why?
|
| Mice | 18 | 2024 | 12537 | 0.330 |
Why?
|
| Cell Movement | 7 | 2016 | 816 | 0.320 |
Why?
|
| Pancreatic Ducts | 2 | 1999 | 30 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2000 | 1276 | 0.290 |
Why?
|
| Animals | 22 | 2024 | 28891 | 0.270 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1667 | 0.260 |
Why?
|
| Stromal Cells | 4 | 2009 | 152 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 996 | 0.220 |
Why?
|
| Nervous System Neoplasms | 1 | 2003 | 11 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 701 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 2 | 1999 | 725 | 0.200 |
Why?
|
| Humans | 38 | 2024 | 96105 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 1215 | 0.190 |
Why?
|
| Methyltransferases | 1 | 2024 | 213 | 0.190 |
Why?
|
| Molecular Sequence Data | 6 | 2009 | 3040 | 0.190 |
Why?
|
| Peptide Fragments | 1 | 2004 | 477 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 6 | 2007 | 1049 | 0.190 |
Why?
|
| Valproic Acid | 3 | 2012 | 25 | 0.180 |
Why?
|
| Heterografts | 2 | 2019 | 117 | 0.180 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 247 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2012 | 528 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 120 | 0.160 |
Why?
|
| Apoptosis | 4 | 2019 | 1756 | 0.160 |
Why?
|
| Transfection | 5 | 2010 | 908 | 0.150 |
Why?
|
| Prognosis | 7 | 2024 | 4028 | 0.150 |
Why?
|
| Azacitidine | 4 | 2018 | 150 | 0.150 |
Why?
|
| NIH 3T3 Cells | 2 | 2011 | 112 | 0.150 |
Why?
|
| Epigenomics | 1 | 2019 | 109 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 50 | 0.140 |
Why?
|
| Antineoplastic Agents | 5 | 2012 | 2418 | 0.140 |
Why?
|
| Inflammation | 1 | 2024 | 1063 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 2090 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1316 | 0.130 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2018 | 61 | 0.130 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 70 | 0.130 |
Why?
|
| Infant | 7 | 2024 | 3363 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2016 | 40 | 0.120 |
Why?
|
| Zonula Occludens-2 Protein | 3 | 2000 | 11 | 0.120 |
Why?
|
| Formaldehyde | 1 | 2016 | 53 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 79 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 187 | 0.120 |
Why?
|
| Epigenesis, Genetic | 5 | 2013 | 555 | 0.120 |
Why?
|
| Disease Progression | 2 | 2010 | 1562 | 0.120 |
Why?
|
| Cell Survival | 1 | 2016 | 1030 | 0.110 |
Why?
|
| Neoplasms | 1 | 2009 | 3248 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2016 | 382 | 0.110 |
Why?
|
| Female | 16 | 2024 | 50028 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 301 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2018 | 591 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 37 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2010 | 477 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 326 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 165 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 445 | 0.090 |
Why?
|
| Caspase 8 | 2 | 2013 | 35 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 57 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 50 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 437 | 0.090 |
Why?
|
| Hypoxia | 1 | 2016 | 681 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2011 | 90 | 0.090 |
Why?
|
| Child | 5 | 2024 | 7625 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 206 | 0.080 |
Why?
|
| Quinoxalines | 1 | 2011 | 51 | 0.080 |
Why?
|
| Genomics | 1 | 2016 | 857 | 0.080 |
Why?
|
| Histones | 3 | 2024 | 363 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2007 | 60 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 439 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1798 | 0.080 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Gene Silencing | 3 | 2004 | 181 | 0.080 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2009 | 10 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 306 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Thrombospondins | 1 | 2009 | 15 | 0.080 |
Why?
|
| Pyridines | 1 | 2011 | 319 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1809 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2001 | 897 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 157 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 76 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 706 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2024 | 3974 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2009 | 360 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 190 | 0.070 |
Why?
|
| Thrombospondin 1 | 2 | 2010 | 22 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 1094 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 1192 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 298 | 0.070 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2007 | 4 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 611 | 0.070 |
Why?
|
| Base Sequence | 3 | 1999 | 2344 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 883 | 0.070 |
Why?
|
| Male | 10 | 2024 | 45863 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 376 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 465 | 0.060 |
Why?
|
| Cell Division | 3 | 2003 | 705 | 0.060 |
Why?
|
| Neoplasm Transplantation | 4 | 2011 | 411 | 0.060 |
Why?
|
| Peptides | 1 | 2010 | 671 | 0.060 |
Why?
|
| Calcium | 1 | 2011 | 1205 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2161 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2939 | 0.060 |
Why?
|
| Methylation | 1 | 2007 | 295 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2009 | 796 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2007 | 193 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2534 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2019 | 2614 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 116 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 272 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 215 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2011 | 516 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 1828 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 184 | 0.050 |
Why?
|
| Cytokines | 1 | 2007 | 871 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 750 | 0.050 |
Why?
|
| Introns | 2 | 2000 | 304 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 295 | 0.050 |
Why?
|
| Exons | 2 | 2000 | 454 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2009 | 3581 | 0.050 |
Why?
|
| Prostaglandin D2 | 1 | 2001 | 28 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 553 | 0.040 |
Why?
|
| Acetylation | 2 | 2012 | 149 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 76 | 0.040 |
Why?
|
| Urothelium | 1 | 2001 | 69 | 0.040 |
Why?
|
| Adenosine | 1 | 2024 | 278 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 125 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1137 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2012 | 107 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 558 | 0.040 |
Why?
|
| Androgens | 1 | 2001 | 179 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 54 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 296 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 547 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1535 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 120 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 258 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 1999 | 134 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 213 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 656 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 542 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 120 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 164 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 256 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 382 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 130 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2004 | 1730 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2001 | 2090 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1471 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 44 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2642 | 0.030 |
Why?
|
| Neurons | 1 | 2005 | 1653 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 930 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 393 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 901 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 3110 | 0.030 |
Why?
|
| Azepines | 1 | 2013 | 28 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1320 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 1196 | 0.020 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2013 | 40 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 85 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2013 | 164 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 28721 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 9895 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 586 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 65 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 393 | 0.020 |
Why?
|
| G1 Phase | 1 | 2012 | 66 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1973 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 69 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 793 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 304 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 216 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 86 | 0.020 |
Why?
|
| Tretinoin | 1 | 2012 | 131 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 102 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 278 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 99 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2086 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 769 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 32 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2880 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 1069 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 304 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 50 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 142 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Pericytes | 1 | 2009 | 14 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 37 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 750 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 644 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 7025 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 132 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 83 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2007 | 132 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 473 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 9175 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 1881 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 2 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2005 | 6 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 526 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 48 | 0.010 |
Why?
|
| Ganglioneuroma | 1 | 2004 | 9 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 67 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 27 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2005 | 53 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 124 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 60 | 0.010 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Collagen Type IV | 1 | 2004 | 28 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 74 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2005 | 231 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 2578 | 0.010 |
Why?
|
| CpG Islands | 1 | 2003 | 169 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2004 | 244 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1930 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 740 | 0.010 |
Why?
|
| Chromans | 1 | 2001 | 29 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 130 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1985 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 478 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 1999 | 14 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2001 | 179 | 0.010 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1999 | 41 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 394 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 548 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 639 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 220 | 0.010 |
Why?
|
| Cell Line | 1 | 2001 | 2537 | 0.010 |
Why?
|
| Alleles | 1 | 1999 | 1157 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 829 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 20968 | 0.000 |
Why?
|